Evaluating the feasibility of using an electronic patient-reported outcome (ePRO) Smartphone Application (app) and Biosensor by Patients with Cancer undergoing Systemic Treatments
This poster describes the design of an ongoing, multi-center, prospective, cohort-based, observational study (ISRCTN25569053) in patients with a biopsy-proven solid tumor diagnosis of cancer who are undergoing systemic cancer treatment. The study aims to examine the feasibility and usability of an electronic patient-reported outcome app paired with a smartwatch biosensor to identify patients who are at high risk for emergency department and unplanned hospital inpatient visits.
{{assetTitle}}
{{assetDescription}}
You are Leaving Medically
By following this link, you are leaving Roche Website and entering a site that is not owned or controlled by Roche. Roche does not take any responsibility for acces to or use of this website, nor for any content therein.
You are Leaving the Global Medically Site
By following this link, you are being redirected to another Roche page.